Serum endocan levels in women with restless legs syndrome

Kenan Celik,1 Mehmet A Cikrikcioglu,1 Gulistan Halac,2 Elif Kilic,3 Siddika Ayhan,3 Nihal Ozaras,4 Kemal Yildiz,5 Rabia S Yildiz,1 Mehmet Zorlu,1 Cumali Karatoprak,1 Mustafa Cakirca,1 Muharrem Kiskac1 1Department of Internal Medicine, 2Department of Neurology, 3Department of Biochemistry, 4Departme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Celik K, Cikrikcioglu MA, Halac G, Kilic E, Ayhan S, Ozaras N, Yildiz K, Yildiz RS, Zorlu M, Karatoprak C, Cakirca M, Kiskac M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/98c862b34f9c49ddadbcc2bbe96c7b7f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:98c862b34f9c49ddadbcc2bbe96c7b7f
record_format dspace
spelling oai:doaj.org-article:98c862b34f9c49ddadbcc2bbe96c7b7f2021-12-02T08:08:55ZSerum endocan levels in women with restless legs syndrome1178-2021https://doaj.org/article/98c862b34f9c49ddadbcc2bbe96c7b7f2015-11-01T00:00:00Zhttps://www.dovepress.com/serum-endocan-levels-in-women-with-restless-legs-syndrome-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Kenan Celik,1 Mehmet A Cikrikcioglu,1 Gulistan Halac,2 Elif Kilic,3 Siddika Ayhan,3 Nihal Ozaras,4 Kemal Yildiz,5 Rabia S Yildiz,1 Mehmet Zorlu,1 Cumali Karatoprak,1 Mustafa Cakirca,1 Muharrem Kiskac1 1Department of Internal Medicine, 2Department of Neurology, 3Department of Biochemistry, 4Department of Physical Medicine and Rehabilitation, Medical Faculty, Bezmialem Vakif University, Fatih, 5Department of Internal Medicine, Private Medicana International Istanbul Hospital, Beylikdüzü, Istanbul, Turkey Background: Endocan is a recently introduced marker of endothelial dysfunction. The objective of this study was to compare serum endocan levels in patients with restless legs syndrome (RLS) and control subjects in order to elucidate whether RLS is associated with endothelial dysfunction. Methods: A total of 31 drug naïve female patients with RLS and 31 age- and BMI-matched women were included in the study. Patients with pathological or physiological conditions or with a history of medication use that could potentially influence endothelial functions were excluded, as well as those with alcohol or drug abuse history. The two groups were compared with routine blood tests and serum endocan levels. Results: Patients with RLS had lower serum endocan levels than the controls (P=0.037). There was a negative bivariate correlation between RLS severity score and serum endocan levels (r=-0.406, P=0.023). While white blood cell count was significantly higher in RLS group, 25-hydroxy vitamin D3, vitamin B12, transferrin saturation rate, and HDL-cholesterol were significantly lower. Creatininemia and diastolic blood pressure were also marginally insignificantly lower in RLS group. Due to the presence of differences between two groups in these variables, a linear regression analysis was performed that showed a positive association between endocan and creatininemia (β=0.310, P=0.022), and a negative association between endocan and RLS (β=-0.502, P<0.001). Conclusion: The results of this study seem to suggest that patients with RLS may have better endothelial functions when compared with the general population and that these patients may be better protected against atherosclerosis. Keywords: endocan, restless legs syndrome, RLS, atherosclerosis, endothelial Celik KCikrikcioglu MAHalac GKilic EAyhan SOzaras NYildiz KYildiz RSZorlu MKaratoprak CCakirca MKiskac MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 2919-2925 (2015)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Celik K
Cikrikcioglu MA
Halac G
Kilic E
Ayhan S
Ozaras N
Yildiz K
Yildiz RS
Zorlu M
Karatoprak C
Cakirca M
Kiskac M
Serum endocan levels in women with restless legs syndrome
description Kenan Celik,1 Mehmet A Cikrikcioglu,1 Gulistan Halac,2 Elif Kilic,3 Siddika Ayhan,3 Nihal Ozaras,4 Kemal Yildiz,5 Rabia S Yildiz,1 Mehmet Zorlu,1 Cumali Karatoprak,1 Mustafa Cakirca,1 Muharrem Kiskac1 1Department of Internal Medicine, 2Department of Neurology, 3Department of Biochemistry, 4Department of Physical Medicine and Rehabilitation, Medical Faculty, Bezmialem Vakif University, Fatih, 5Department of Internal Medicine, Private Medicana International Istanbul Hospital, Beylikdüzü, Istanbul, Turkey Background: Endocan is a recently introduced marker of endothelial dysfunction. The objective of this study was to compare serum endocan levels in patients with restless legs syndrome (RLS) and control subjects in order to elucidate whether RLS is associated with endothelial dysfunction. Methods: A total of 31 drug naïve female patients with RLS and 31 age- and BMI-matched women were included in the study. Patients with pathological or physiological conditions or with a history of medication use that could potentially influence endothelial functions were excluded, as well as those with alcohol or drug abuse history. The two groups were compared with routine blood tests and serum endocan levels. Results: Patients with RLS had lower serum endocan levels than the controls (P=0.037). There was a negative bivariate correlation between RLS severity score and serum endocan levels (r=-0.406, P=0.023). While white blood cell count was significantly higher in RLS group, 25-hydroxy vitamin D3, vitamin B12, transferrin saturation rate, and HDL-cholesterol were significantly lower. Creatininemia and diastolic blood pressure were also marginally insignificantly lower in RLS group. Due to the presence of differences between two groups in these variables, a linear regression analysis was performed that showed a positive association between endocan and creatininemia (β=0.310, P=0.022), and a negative association between endocan and RLS (β=-0.502, P<0.001). Conclusion: The results of this study seem to suggest that patients with RLS may have better endothelial functions when compared with the general population and that these patients may be better protected against atherosclerosis. Keywords: endocan, restless legs syndrome, RLS, atherosclerosis, endothelial 
format article
author Celik K
Cikrikcioglu MA
Halac G
Kilic E
Ayhan S
Ozaras N
Yildiz K
Yildiz RS
Zorlu M
Karatoprak C
Cakirca M
Kiskac M
author_facet Celik K
Cikrikcioglu MA
Halac G
Kilic E
Ayhan S
Ozaras N
Yildiz K
Yildiz RS
Zorlu M
Karatoprak C
Cakirca M
Kiskac M
author_sort Celik K
title Serum endocan levels in women with restless legs syndrome
title_short Serum endocan levels in women with restless legs syndrome
title_full Serum endocan levels in women with restless legs syndrome
title_fullStr Serum endocan levels in women with restless legs syndrome
title_full_unstemmed Serum endocan levels in women with restless legs syndrome
title_sort serum endocan levels in women with restless legs syndrome
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/98c862b34f9c49ddadbcc2bbe96c7b7f
work_keys_str_mv AT celikk serumendocanlevelsinwomenwithrestlesslegssyndrome
AT cikrikciogluma serumendocanlevelsinwomenwithrestlesslegssyndrome
AT halacg serumendocanlevelsinwomenwithrestlesslegssyndrome
AT kilice serumendocanlevelsinwomenwithrestlesslegssyndrome
AT ayhans serumendocanlevelsinwomenwithrestlesslegssyndrome
AT ozarasn serumendocanlevelsinwomenwithrestlesslegssyndrome
AT yildizk serumendocanlevelsinwomenwithrestlesslegssyndrome
AT yildizrs serumendocanlevelsinwomenwithrestlesslegssyndrome
AT zorlum serumendocanlevelsinwomenwithrestlesslegssyndrome
AT karatoprakc serumendocanlevelsinwomenwithrestlesslegssyndrome
AT cakircam serumendocanlevelsinwomenwithrestlesslegssyndrome
AT kiskacm serumendocanlevelsinwomenwithrestlesslegssyndrome
_version_ 1718398614960603136